Stock-Based Compensation (Tables)

3 Months Ended

Oct. 27, 2012

Stock-based compensation expense by type

The compensation costs that have been charged against income for the thirteen and thirty-nine weeks ended October 27, 2012 and October 29, 2011 were as follows (in thousands):

	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
	October 27,		October 29,		October 27,		October 29,
	2012		2011		2012		2011
Stock-based compensation expense by type:
Stock options	$	32	$	19	$	774	$	442
Restricted stock unit awards, including performance-based		1,024		1,594		3,978		4,214
Employee stock purchase		16		19		51		60
Director deferred compensation		15		15		21		45
Total stock-based compensation expense		1,087		1,647		4,824		4,761
Income tax benefit recognized		403		604		1,797		1,747
Stock-based compensation expense, net of income tax	$	684	$	1,043	$	3,027	$	3,014

Equity awards granted during the period

In the thirteen and thirty-nine weeks ended October 27, 2012 and October 29, 2011, we granted the following equity awards:

	Thirteen Weeks Ended		Thirty-Nine Weeks Ended
	October 27,	October 29,	October 27,	October 29,
	2012	2011	2012	2011
Stock options	1,530	1,341	39,772	34,551
Restricted stock unit awards	2,801	1,000	66,317	103,143
Performance-based restricted stock unit awards	-	-	38,100	53,000
Deferred stock units	252	442	361	1,229

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details